INVESTIGATION ALERT: Kaskela Law LLC Announces Stockholder Investigation of R1 RCM Inc. (RCM) in Connection with Recent Merger Announcement

Philadelphia, Pennsylvania--(Newsfile Corp. - February 27, 2022) - Investor protection firm Kaskela Law LLC announces that is investigating the Board of Directors of R1 RCM Inc. (NASDAQ: RCM) on behalf of the company's stockholders.

On January 10, 2022, R1 RCM announced that it had entered into a definitive agreement to acquire Cloudmed in an all-stock transaction valued at $4.1 billion. According to the announcement, R1 RCM is expected to issue approximately 138 million shares of RCM stock to Cloudmed shareholders who are, as a result, expected to own approximately 30% of the combined company.

The investigation seeks to determine whether the members of R1 RCM's Board of Directors violated the securities laws or breached their fiduciary duties to RCM shareholders in connection with the proposed transaction, and whether R1 RCM shareholders are being provided with all material information in connection with the proposed merger.

R1 RCM shareholders are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 - 0750, or by email (abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/r1-rcm-inc/, for additional information about this investigation and their legal rights and options.

Kaskela Law LLC represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.

CONTACT:

D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 - 0750
(888) 715 - 1740
www.kaskelalaw.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/115046